Aixin Life files 8-K/A with unaudited financials for two acquisitions; Shangyan Hotel reports H1 2021 net loss of $481K

AiXin Life International, Inc.

Shangyan Co revenue $748,056 for six months ended June 30, 2021; net loss $481,453.
Shangyan Co total assets $2.43M, stockholders' deficit $1.97M as of June 30, 2021.
Pharmacy Co unaudited financials for same period and pro forma combined statements also filed.
Acquisitions of Shangyan Co (RMB 7.6M/$1.16M) and Pharmacy Co were announced in May/June 2021; this amendment provides updated financials.
Shangyan Co operating loss $534,022 for H1 2021 versus $434,754 loss in H1 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.